Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A(2A) receptor antagonist

Brain Research

Volumn 800, Issue 2, 1998, Pages 328-335

  Jones, P A ^b   Smith, R A ^a   Stone, T W ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b W Med Bldg Univ Glasgow G ^*

Author keywords

A2 receptors; Adenosine; CGS21680; Excitotoxicity; Hippocampus; Kainate; Purines; ZM241385

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; KAINIC ACID; PHENYLISOPROPYLADENOSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOSE RESPONSE; HIPPOCAMPUS; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; MALE; NEUROTOXINS; PHENETHYLAMINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2; TRIAZINES; TRIAZOLES;

EID: 0032479984     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00540-X     Document Type: Article

References (41)

1. Ameri A., Jurna I. Adenosine A1 and non-A1 receptors: intracellular analysis of the actions of agonists and antagonists in rat hippocampal slices. Brain Res. 546:1991;69-78.
2. Arvin B., Neville L.F., Pan J., Roberts P.J. 2-Chloroadenosine attenuates kainic acid induced toxicity within the rat striatum: relationship to release of glutamate and calcium influx. Br. J. Pharmacol. 98:1989;225-253.
3. Brown A.W., Brierley J.B. Anoxic ischaemic cell change in the rat brain. Light microscope and fine structural observations. J. Neurol. Sci. 16:1972;15-84.
4. 3H]NECA in rat striatal membranes Mol. Pharmacol. 29:1986;331-346.
5. Carswell H.V., Graham D.I., Stone T.W. Kainate-evoked release of adenosine from the hippocampus of the anaesthetised rat: possible involvement of free radicals. J. Neurochem. 68:1997;240-247.
6. Chen Y., Graham D.I., Stone T.W. Release of endogenous adenosine and its metabolites by the activation of NMDA receptors in the rat hippocampus in vivo. Br. J. Pharmacol. 106:1992;632-638.
7. Connick J.H., Stone T.W. Quinolinic acid neurotoxicity: protection by intracerebral phenylisopropyladenosine (PIA) and potentiation by hypotension. Neurosci. Lett. 101:1989;191-196.
8. Corradetti R., Lo Conte G., Moroni F. Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur. J. Phamacol. 104:1984;19-26.
9. 2a receptors in the rat hippocampus. Brain Res. 649:1994;208-216.
10. 3H]CGS21680 in the rat hippocampus and cerebral cortex that are different from striatal A(2A) receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;261-271.
11. Cronstein B.N. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:1994;5-13.
12. 2A receptor in the rat striatum. J. Neurochem. 69:1997;315-321.
13. Gerber U., Greene R.W., Haas H.L., Stevens D.R. Characterisation of inhibition mediated by adenosine in the hippocampus of the rat in vitro. J. Physiol. 417:1989;567-578.
14. 2+ uptake through class A calcium channels in rat hippocampal CA3 but not CA1 synaptosomes. Neurosci. Lett. 238:1997;73-77.
15. Heggli D.A., Aamodt A., Malthe-Sorenssen D. Kainic acid neurotoxicity, effects of systemic injection on neurotransmission markers in different brain regions. Brain Res. 230:1981;253-262.
16. Heron A., Lasbennes F., Seylez J. Adenosine modulation of amino acid release in rat hippocampus during ischaemia and veratridine depolarisation. Brain Res. 608:1993;27-32.
17. 2 selective adenosine receptor agonist with preferential hypotensive activity. J. Pharmacol. Exp. Ther. 251:1989;47-55.
18. 3H]CGS21680 Eur. J. Pharmacol. 168:1989;243-246.
19. 2A receptor agonists and antagonists. Neuroscience. 85:1998;229-238.
20. Jorgensen M.B. The role of signal transduction in the delayed necrosis of the hippocampal CA1 pyramidal cells following transient ischaemia. Acta Neurol. Scand. 87:1993;1-20. Supplement 143.
21. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioural, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
22. Lupica C.R., Cass W.A., Zahniser N.R., Dunwiddie T.V. Effects of the selective adenosine agonist CGS21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. J. Pharmacol. Exp. Ther. 252:1990;1134-1141.
23. 6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administration. Br. J. Pharmacol. 109:1993;316-321.
24. Macgregor D.G., Miller W.J., Stone T.W. Mediation of the neuroprotective action of R-phenylisopropyladenosine through a centrally located adenosine A1 receptor. Br. J. Pharmacol. 110:1993;470-476.
25. Macgregor D.G., Jones P.A., Graham D.I., Stone T.W. Prevention by a purine analogue of kainate-induced neuropathology in rat hippocampus. Brain Res. 725:1996;115-120.
26. Magloczky Z., Freund T.F. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield. Neuroscience. 56:1993;317-336.
27. 2 receptor agonists and antagonists on local rates of energy metabolism in the rat brain. Eur. J. Pharmacol. 258:1994;57-66.
28. 2 receptor-mediated responses on rat hippocampal neurones. Br. J. Pharmacol. 122:1997;287P.
29. 2 adenosine receptor agonist CGS21680 enhances excitatory amino acid release from the ischaemic rat cerebral cortex. Neurosci. Lett. 138:1992;169-172.
30. 2a adenosine receptor Mol. Pharmacol. 48:1995;970-974.
31. G. Paxinos, C. Watson, The Rat Brain In Stereotaxic Coordinates, Academic Press, 1986.
32. Poli A., Lucchi R., Vibio M., Barnabei O. Adenosine and glutamate modulate each other's release from rat hippocampal synaptosomes. J. Neurochem. 57:1991;298-306.
33. 2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur. J. Pharmacol. 287:1995;215-217.
34. 2a receptor agonist CGS 2168021680. Drug Dev. Res. 39:1996;108-114.
35. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 42:1994;1-32.
36. Stella L., De Novellis V., Berrino L., D'amico M., Rossi F. Evidence that A(2a) and not A(2b) purinoceptors are coupled to production of nitric oxide in the regulation of blood pressure. Environ. Toxicol. Pharmacol. 2:1996;327-329.
37. Thompson S.M., Haas H.L., Gahwiler B. Comparison of the actions of adenosine at pre- and post-synaptic receptors in the rat hippocampus in vitro. J. Physiol. 451:1992;347-363.
38. 2 receptors mediate cerebral vasodilation in the conscious goat. Blood Vessels. 27:1990;24-27.
39. Von Lubitz D.J.K.E., Dambrosia J.M., Kempski O., Redmond D.J. Cyclohexyladenosine protects against neuronal death following ischaemia in the CA1 region of gerbil hippocampus. Stroke. 19:1988;1133-1139.
40. 2a receptor agonist and antagonist. Eur. J. Pharmacol. 287:1995;295-302.
41. Zetterstrom T., Vernet L., Ungerstedt U., Tossman U., Jonzon B., Fredholm B.B. Purine levels in the intact brain studied with an implanted perfused hollow fibre. Neurosci. Lett. 29:1982;111-115.